Titlebook: Immunological Adjuvants and Vaccines; Gregory Gregoriadis,Anthony C. Allison,George Post Book 1989 Springer Science+Business Media New Yor

無力向前

書目名稱Immunological Adjuvants and Vaccines影響因子(影響力)




書目名稱Immunological Adjuvants and Vaccines影響因子(影響力)學科排名




書目名稱Immunological Adjuvants and Vaccines網(wǎng)絡(luò)公開度




書目名稱Immunological Adjuvants and Vaccines網(wǎng)絡(luò)公開度學科排名




書目名稱Immunological Adjuvants and Vaccines被引頻次




書目名稱Immunological Adjuvants and Vaccines被引頻次學科排名




書目名稱Immunological Adjuvants and Vaccines年度引用




書目名稱Immunological Adjuvants and Vaccines年度引用學科排名




書目名稱Immunological Adjuvants and Vaccines讀者反饋




書目名稱Immunological Adjuvants and Vaccines讀者反饋學科排名

明確

動作謎

exclamation

柏樹

Nonionic Block Copolymer Surfactants as Immunological Adjuvants: Mechanisms of Action and Novel Forc interactions between various ligands and their receptors. From our perspective, producing effective adjuvants for subunit vaccines will require looking beyond this paradigm to a consideration of nonspecific physicochemical factors which subtly but powerfully influence immune responses.

Atheroma

執(zhí)拗

Chemical Events in Immune Induction: Evidence for a Covalent Intercellular Reaction Essential in Ans at the chemical level in the inductive interaction between class II positive APC and T-cell. Remarkably, the evidence reviewed here shows that a covalent reaction occurs between ligands on the APC surface and the T-cell surface and that the formation of these reversible covalent bonds is an essential process in antigen-induced T-cell activation.

結(jié)果

Liposomes as Carriers of Vaccines: Development of a Liposomal Malaria Vaccine,liposomes to certain tissues can be achieved by the use of special biophysically or biochemically tailored liposomes (Hwang et al, 1980; Gregoriadis et al, 1982; Allen and Chonn, 1987; Papahadjopoulos and Gabizon, 1987; Gabizon and Papahadjopoulos, 1988).

碳水化合物

Immunostimulating Complex (ISCOM),risk for induction autoimmune or allergic reactions. (iii) Further, reorganization of the prospective protective antigens may break a strategy for survival of the pathogen in the “hostile” immunological environment of the infected host.

SEEK